Athena Pharma Private Limited

Athena Pharma Private Limited - pharma in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
CIN U85100MH2009PTC197868 Incorporated 15 December 2009 ROC Mumbai HQ Mumbai, Maharashtra, India
Active Private Limited Company pharma
Data last updated
Revenue · FY 2024
₹2.51 Cr
▼ 76% YoY
Net loss · FY 2024
₹38.93 Lakh
Net margin -15.5%
EBITDA · FY 2024
-₹35.06 Lakh
EBITDA margin -14%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Satisfied charges
₹16 Lakh
No open charges
Company age
17 yrs
Est. 2009
Directors on board
2
As per MCA filings

About Athena Pharma Private Limited

Data last updated:

Athena Pharma Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 15 December 2009 and has been in existence for over 17 years.

The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U85100MH2009PTC197868. Its GSTIN is 27AAICA2039A1Z7 (Maharashtra).

The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Vikrant Dhruvaraj Singh and Dhruvaraj Indrapal Singh.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Mumbai, Maharashtra.

As per the financials filed for FY 2024, the company reported a revenue of ₹2.51 Cr, a decline of 76% compared to the previous year. For the same year it recorded a net loss of ₹38.93 Lakh (net margin -15.5%) and EBITDA of -₹35.06 Lakh (EBITDA margin -14%). Revenue has declined at a compounded annual rate (CAGR) of 37% over three years and 6% over five years.

As per MCA filings, the company has satisfied charges of ₹16 Lakh on record.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website athenapharma.in.

Company Details of Athena Pharma Private Limited
CIN U85100MH2009PTC197868
Registration Number 197868
Incorporation Date 15 December 2009
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Social Media
    Locked
  • Registered Address
    Unit No 620 Prestige Industrial Estate Bawdi Cross Lane Off Marve Road Malad, (West), Mumbai, Maharashtra, India – 400064
  • Industry
    Pharma, Pharmaceutical Retailers & Distributors
Comprehensive company report
Athena Pharma Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
  • One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Unlock the full Athena Pharma Private Limited report

Financials, compliance, directors, charges, ownership and filings for Athena Pharma Private Limited in one report.

Financials from 2015 Directors & ownership Charges & compliance

Business Activity of Athena Pharma Private Limited

The main business activity of Athena Pharma is trade. In detail, this covers wholesale trading.

Main Activity Group CodeDescription of Main ActivityBusiness Activity CodeDescription of Business ActivityTurnover Percentage
GTradeG1Wholesale TradingLocked
Premium access

Business activity turnover details

Turnover share and past changes in activity are in the company report.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Financials of Athena Pharma Private Limited FY 2025 filings available

Athena Pharma Private Limited reported revenue of ₹2.51 Cr (down 76% YoY) for FY 2024.

Revenue · FY 2024
₹2.51 Cr ▼ 76%
Net loss · FY 2024
₹38.93 Lakh margin -15.5%
EBITDA · FY 2024
-₹35.06 Lakh margin -14%

Compounded Annual Growth Rate (CAGR) of Athena Pharma Private Limited

Revenue CAGR growth
1 year
▼ 76%
3 years · compounded
▼ 37%
5 years · compounded
▼ 6%
EBITDA CAGR growth
1 year
▼ 146%
3 years · compounded
▼ 35%
5 years · compounded
▼ 28%

Revenue has declined at a compounded annual rate (CAGR) of 6% over five years, including a 76% fall in the latest year. EBITDA fell 146% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary of Athena Pharma Private Limited

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profit and Loss Statement
Revenue from Operations••••••••••••••••••••
Other Income••••••••••••••••••••
Total Revenue••••••••••••••••••••
Cost of Materials Consumed••••••••••••••••••••
Employee Benefit Expense••••••••••••••••••••
Finance Costs••••••••••••••••••••
Depreciation and Amortisation••••••••••••••••••••
Other Expenses••••••••••••••••••••
Total Expenses••••••••••••••••••••
EBITDA-₹35.06 Lakh••••••••••••••••
Profit Before Tax••••••••••••••••••••
Tax Expense••••••••••••••••••••
Net Profit (PAT)-₹38.93 Lakh••••••••••••••••
Balance Sheet
Share Capital••••••••••••••••••••
Reserves and Surplus••••••••••••••••••••
Net Worth (Total Equity)••••••••••••••••••••
Long-term Borrowings••••••••••••••••••••
Short-term Borrowings••••••••••••••••••••
Trade Payables••••••••••••••••••••
Total Liabilities••••••••••••••••••••
Fixed Assets••••••••••••••••••••
Investments••••••••••••••••••••
Inventories••••••••••••••••••••
Trade Receivables••••••••••••••••••••
Cash and Bank Balance••••••••••••••••••••
Total Assets••••••••••••••••••••

Financial Ratios of Athena Pharma Private Limited

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profitability
EBITDA Margin-14%••••••••••••••••
Net Profit Margin-15.5%••••••••••••••••
Return on Equity (ROE)••••••••••••••••••••
Return on Capital Employed (ROCE)••••••••••••••••••••
Return on Assets (ROA)••••••••••••••••••••
Liquidity and Debt
Current Ratio••••••••••••••••••••
Quick Ratio••••••••••••••••••••
Debt-to-Equity Ratio••••••••••••••••••••
Interest Coverage Ratio••••••••••••••••••••
Efficiency and Growth
Asset Turnover••••••••••••••••••••
Receivable Days••••••••••••••••••••
Payable Days••••••••••••••••••••
Inventory Days••••••••••••••••••••
Revenue Growth••••••••••••••••••••
Net Profit Growth••••••••••••••••••••

Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Athena Pharma are in the company report.

Premium access

Financial statements from 2015

Earlier years and trend charts are in the company report.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Board of Directors of Athena Pharma Private Limited

Athena Pharma has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Vikrant Dhruvaraj SinghDirector15 Dec 200916 Years 10 MonthsCurrent
Dhruvaraj Indrapal SinghDirector18 May 201214 Years 5 MonthsCurrent

Peer Comparison of Athena Pharma Private Limited

Athena Pharma Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution). Net profit, margin and employee counts of each company are in the company report.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Paam Antibiotics Limited₹2.53 Cr (FY 2025)••••••••-31.0%••••Delhi, India
Park Medicity (Haryana) Private Limited₹2.53 Cr (FY 2025)••••••••19.0%••••New Delhi, Delhi, India
Warehouster Capital Advisors India Private Limited₹2.52 Cr (FY 2024)••••••••120.0%••••Mumbai, Maharashtra, India
Agnitio Solutions Private Limited₹2.52 Cr (FY 2024)••••••••4.0%••••Noida, Uttar Pradesh, India
Novo Medix Pharmaceutical Private Limited₹2.52 Cr (FY 2025)••••••••2.0%••••Kolkata, West Bengal, India
Athena Pharma Private Limited this company₹2.51 Cr (FY 2024)••••••••-76.0%••••Mumbai, Maharashtra, India
Viprav Ventures India Private Limited₹2.51 Cr (FY 2025)••••••••41.0%••••Raipur, Chhattisgarh, India
Celosia Pharmaceutical Private Limited₹2.51 Cr (FY 2025)••••••••11.0%••••Chennai, Tamil Nadu, India
Naatson Healthcare Private Limited₹2.5 Cr (FY 2024)••••••••10.0%••••Chennai, Tamil Nadu, India
Erinaa Healthcare Private Limited₹2.49 Cr (FY 2025)••••••••9.0%••••North 24 Parganas, West Bengal, India
N. V. Lifecare Private Limited₹2.49 Cr (FY 2017)••••••••12.0%••••Ahmedabad, Gujarat, India

Peers are the five companies nearest above and the five nearest below Athena Pharma by revenue in the Pharma industry (Pharma Retail and Distribution), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.

Auditor Details of Athena Pharma Private Limited

Athena Pharma Private Limited is audited by N.H.Shah & Associates for the financial year 2023.

NameStatusAppointment DateCessation Date
N.H.Shah & AssociatesLockedLockedLocked
Premium access

Complete auditor history

Appointment and cessation dates and past auditor changes are in the company report.

  • Appointment status
  • Appointment dates
  • Cessation dates
  • Auditor changes

Verified entity values are shown only after access is granted.

Ownership and Shareholding of Athena Pharma Private Limited

Premium access

Shareholding and ownership data

Promoter, institutional, public and beneficial ownership figures are in the company report.

  • Ownership categories
  • Historical changes
  • Group structure
  • FII and DII holdings

Verified entity values are shown only after access is granted.

Charges & Borrowings of Athena Pharma Private Limited

Open charges
None
Satisfied charges
₹16 Lakh
Breakdown by lending institutions
Others₹0.16 Cr
Latest charge details
DateLenderAmountStatus
12 Oct 2021Others₹16 LakhSatisfied

Total charge records: 1 View all charges

Employees and EPFO Compliance at Athena Pharma Private Limited

Employment history and EPFO contributions of people linked to Athena Pharma.

Premium access

Employee and EPFO history

Monthly headcount, contribution history and filing status are in the company report.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

Recent Activity on Athena Pharma Private Limited

Athena Pharma Private Limited has 4 board changes on record since 2009: 2 appointments and 2 cessations. The latest: Dhruvaraj Indrapal Singh ceased to be Additional Director on 27 Sep 2012.

AGM
Athena Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Athena Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai.
Charges
A charge registered on 12 Oct 2021 via Charge ID 100496336 with Others was fully satisfied on 09 May 2023.
Charges
A charge with Others amounted to Rs. 16.00 Lakh with Charge ID 100496336 was registered on 12 Oct 2021.
Ceased
Dhruvaraj Indrapal Singh ceased to be Additional Director.
Appointed
Dhruvaraj Indrapal Singh was appointed as Director.
Ceased
Paramjitsingh Ratansingh Bhumrah ceased to be Director.
Appointed
Vikrant Dhruvaraj Singh was appointed as Director.
Incorporation
15 Dec 2009
Athena Pharma Private Limited was registered on 15 Dec 2009 with Roc Mumbai & aged 16 years 10 months as per MCA records.

Credit Ratings, Litigation & Regulatory Alerts for Athena Pharma Private Limited

Premium access

Credit ratings, litigation, and regulatory alerts

Credit ratings, court records and regulatory alerts are in the company report.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Athena Pharma Private Limited

Premium access

MSME payment history

Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Athena Pharma Private Limited

Premium access

Corporate group structure

Parent, subsidiary, associate and joint venture records with holdings are in the company report.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

GST Compliance of Athena Pharma Private Limited

Athena Pharma has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
27AAICA2039A1Z7MaharashtraActive01 Jul 2017
Premium access

GST registrations and filing compliance

State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Athena Pharma Private Limited

Premium access

MCA filings and documents

Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Athena Pharma Private Limited

Athena Pharma is an active private limited company based in Mumbai, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 15 December 2009 (17+ years old) and is registered under CIN U85100MH2009PTC197868.

Athena Pharma reported revenue of ₹2.51 Cr for FY 2024 (down 76% YoY).

Athena Pharma has 2 current directors:

Athena Pharma reported a net loss of ₹38.93 Lakh (net margin -15.5%) and EBITDA of -₹35.06 Lakh (EBITDA margin -14%) for FY 2024, as per its filed financial statements.

The compounded annual growth rate (CAGR) of the revenue of Athena Pharma is -37% over three years and -6% over five years. In the latest year (FY 2024) revenue fell 76%. CAGR is the steady yearly rate that links the first and the last year.

The GSTIN of Athena Pharma is 27AAICA2039A1Z7, registered in Maharashtra.

The CIN (Corporate Identification Number) of Athena Pharma is U85100MH2009PTC197868. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Athena Pharma was incorporated on 15 December 2009, making it 17+ years old. It is registered with the Registrar of Companies, Mumbai.

The peers of Athena Pharma by revenue are Paam Antibiotics Limited, Park Medicity (Haryana) Private Limited, Warehouster Capital Advisors India Private Limited, Agnitio Solutions Private Limited, Novo Medix Pharmaceutical Private Limited and 5 more, all in the Pharma industry (Pharma Retail and Distribution).

Dhruvaraj Indrapal Singh ceased to be Additional Director on 27 Sep 2012. Dhruvaraj Indrapal Singh was appointed as Director on 18 May 2012. Paramjitsingh Ratansingh Bhumrah ceased to be Director on 18 May 2012. Athena Pharma has 4 board changes on record in total.

Athena Pharma can be reached through the website athenapharma.in. Its registered office is in Mumbai, Maharashtra, India.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - compiled from official filings and updated regularly.

Subscription plans available